Physician profile
Harshal Sheth
NPI 1639359094
$27,141.42
in general payments reported to CMS, 2019-2025
29 companies · $4,086 in 2025
The $4,086 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,652 · 2020: $1,338 · 2021: $1,805 · 2022: $2,425 · 2023: $6,182 · 2024: $4,654 · 2025: $4,086.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,767 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,250 · Consulting Fee: $2,250 · Travel and Lodging: $1,655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,767.10 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,250.00 |
| Consulting Fee | $2,250.00 |
| Travel and Lodging | $1,655.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $13,851.39 | 2019-2025 | Perclose Prostyle, Absolute Pro, Ensite |
| Boston Scientific Corporation | $6,326.86 | 2019-2025 | General - Therapies, Ingevity+, Farapulse |
| Biosense Webster, INC. | $1,941.89 | 2020-2025 | Carto 3, Qdot Micro, Na |
| Janssen Pharmaceuticals, INC | $1,122.85 | 2019-2024 | Xarelto |
| Abiomed | $626.18 | 2022-2025 | Impella |
| Medtronic, INC. | $617.26 | 2021-2025 | Affera Mapping System, Na, Pulseselect |
| Impulse Dynamics (USA) INC. | $371.24 | 2022-2023 | Optimizer |
| Novo Nordisk INC | $275.01 | 2022-2025 | Ozempic |
| Edwards Lifesciences Corporation | $237.75 | 2023-2025 | Sapien 3 Ultra Resilia, Hemosphere, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boehringer Ingelheim Pharmaceuticals, INC. | $210.72 | 2019-2023 | Jardiance |
| Biotronik INC. | $204.76 | 2020-2021 | |
| Amgen INC. | $168.77 | 2021-2025 | Repatha, Repatha |
| Heartflow, INC. | $168.40 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $148.88 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $138.12 | 2021-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $118.47 | 2019-2020 | |
| Cardiva Medical, INC. | $114.07 | 2022-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $108.20 | 2019-2025 | Lifevest |
| Philips North America LLC | $75.87 | 2019-2023 | |
| Cvrx, INC. | $71.44 | 2024-2025 | Barostim Neo System |
| Shockwave Medical, INC | $50.60 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Stryker Corporation | $45.90 | 2025 | |
| Terumo Medical Corporation | $31.41 | 2022 | |
| Esperion Therapeutics, INC. | $31.35 | 2025 | Nexletol |
| Scpharmaceuticals INC. | $19.36 | 2023 | |
| Inspire Medical Systems, INC. | $18.43 | 2023 | Inspire |
| Merck Sharp & Dohme LLC | $17.61 | 2021 | |
| Kestra Medical Technology Services, INC. | $15.49 | 2023 | Assure Wcd |
| Ge Healthcare | $13.14 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harshal Sheth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.